Develops drugs for gastrointestinal diseases and cancer-related diarrhea.
Jun 2026Revenue $27.8M/yrExpenses $53.7M/yr
No trendCash runway ≈ 7 months from Jun 2026
Figures by year
When will Jaguar Health be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $27.8M and expenses $53.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $11.5M | $57.4M | −$45.9M |
| Dec 2024 | $11.7M | $42.5M | −$30.8M |
| Dec 2023 | $9.76M | $44.1M | −$34.3M |
| Dec 2022 | $12.0M | $46.4M | −$34.4M |
| Dec 2021 | $4.33M | $45.0M | −$40.7M |
| Dec 2020 | $9.38M | $36.0M | −$26.6M |
| Dec 2019 | $5.78M | $34.7M | −$28.9M |
| Dec 2018 | $4.42M | $35.2M | −$30.8M |
| Dec 2017 | $4.36M | $38.6M | −$34.2M |
| Dec 2016 | $142K | $13.7M | −$13.6M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.